X-Linked Agammaglobulinemia (XLA):Phenotype, Diagnosis, and Therapeutic Challenges Around the World

• Autor(es): El-Sayed, ZA ; Abramova, I ; Aldave, JC ; Al-Herz, W ; Bezrodnik, L ; Boukari, R ; Bousfiha, AA ; Cancrini, C ; Condino-Neto, A ; Dbaibo, G ; Derfalvi, B ; Dogu, Fi ; Edgar, JDM ; Eley, B ; El-Owaidy, RH ; Espinosa-Padilla, SE ; Galal, N ; Haerynck, F ; Hanna-Wakim, R ; Hossny, E ; Ikinciogullari, A ; Kamal, E ; Kanegane, H ; Kechout, N ; Lau, YL ; Morio, T ; Moschese, V ; Neves, JF ; Ouederni, M ; Paganelli, R ; Paris, K ; Pignata, C ; Plebani, A ; Qamar, FN ; Qureshi, S ; Radhakrishnan, N ; Rezaei, N ; Rosario, N ; Routes, J ; Sanchez, B ; Sediva, A ; Seppanen, MR ; Serrano, EG ; Shcherbina, A ; Singh, S ; Siniah, S ; Spadaro, G ; Tang, M ; Vinet, AM ; Volokha, A ; Sullivan, KE
• Data: 2019
• Identificador Persistente: http://hdl.handle.net/10400.17/3249
• Origem: Repositório do Centro Hospitalar de Lisboa Central, EPE
• Assunto(s): Agammaglobulinemia; Autoimmunity; Chronic Lung Disease; Family History; Gastrointestinal; Immunoglobulin; Juvenile idiopathic arthritis; Subcutaneous Immunoglobulin; Vaccine Associated Paralytic Poliomyelitis; XLA, X-Linked Agammaglobulinemia; HDE PED
• Tipo de Documento: Artigo científico
• Idioma: Inglês
• Contribuidor(es): Repositório da Unidade Local de Saúde São José

Descrição

X-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features.